• Loading stock data...
Slide background


Advisory Board

Morten Albrechtsen, Clinical Advisor

Morten Albrechtsen is an experienced business leader with a strong medical, commercial and financial background. After holding executive positions at several large pharmaceutical companies, including Boehringer Ingelheim and Nycomed (later acquired by Takeda Pharmaceutical), he founded ENKAM Pharmaceuticals in 2001. Since then, he has divided his time between consultancy work and executive roles, primarily at companies 2–4 years prior to cash-generating transactions. In addition to his role at Blake, Morten serves as co-founder and CEO at radiotherapy specialists Nanovi, part-time CEO at a number of pharma-related startups and executive chairman at the clinical CRO NORMA. Known as an expert deal-maker, Morten has extensive experience with turnarounds, spinoffs, business development, licensing and corporate deals, including M&A and financing.